Eva M. Sutinen

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Precision tumor-on-chip for personalized assessment of drug efficacy and immune cell delivery.

Precision tumor-on-chip for personalized assessment of drug efficacy and immune cell delivery.

Journal: Cell reports methods

Published: December 19, 2025

Characterisation of patients with antifibrotic-treated non-idiopathic pulmonary fibrosis progressive pulmonary fibrosis: a retrospective real-life study.

Characterisation of patients with antifibrotic-treated non-idiopathic pulmonary fibrosis progressive pulmonary fibrosis: a retrospective real-life study.

Journal: BMJ open

Published: November 17, 2025

Ex vivo modeling of precision immuno-oncology responses in lung cancer.

Ex vivo modeling of precision immuno-oncology responses in lung cancer.

Journal: Science advances

Published: October 30, 2024

Health-related quality of life measured with K-BILD is associated with survival in patients with idiopathic pulmonary fibrosis.

Health-related quality of life measured with K-BILD is associated with survival in patients with idiopathic pulmonary fibrosis.

Journal: BMC pulmonary medicine

Published: May 10, 2024

Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer.

Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer.

Journal: Oncoimmunology

Published: August 07, 2023

Dyspnea Associates With a Widely Impaired Quality of Life in Idiopathic Pulmonary Fibrosis Patients: A Longitudinal Study Using 15D.

Dyspnea Associates With a Widely Impaired Quality of Life in Idiopathic Pulmonary Fibrosis Patients: A Longitudinal Study Using 15D.

Journal: Journal of palliative medicine

Published: June 27, 2023

KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis.

KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis.

Journal: Respiratory research

Published: June 13, 2023

Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment.

Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment.

Journal: Nature communications

Published: June 08, 2023

Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testing.

Novel therapeutic approaches for pleural mesothelioma identified by functional ex vivo drug sensitivity testing.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 31, 2023

Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma.

Prognostic Role of Tumor Immune Microenvironment in Pleural Epithelioid Mesothelioma.

Journal: Frontiers in oncology

Published: February 06, 2022

Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics.

Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics.

Journal: Cell genomics

Published: January 25, 2022

Pulmonary Asbestos Fiber Burden Is Related to Patient Survival in Malignant Pleural Mesothelioma.

Pulmonary Asbestos Fiber Burden Is Related to Patient Survival in Malignant Pleural Mesothelioma.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: December 20, 2021

Showing 1-12 of 34

Last Updated: 09/26/2026